Nukkleus (NUKK) Competitors $7.90 -0.07 (-0.88%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$8.05 +0.15 (+1.91%) As of 05:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUKK vs. OACC, CIO, FRGE, BROG, SAMG, KVAC, EARN, MACI, PINE, and HLXBShould you be buying Nukkleus stock or one of its competitors? The main competitors of Nukkleus include Oaktree Acquisition Corp. III Life Sciences (OACC), City Office REIT (CIO), Forge Global (FRGE), Brooge Energy (BROG), Silvercrest Asset Management Group (SAMG), Keen Vision Acquisition (KVAC), Ellington Credit (EARN), Melar Acquisition Corp. I (MACI), Alpine Income Property Trust (PINE), and Helix Acquisition Corp. II (HLXB). These companies are all part of the "trading" industry. Nukkleus vs. Its Competitors Oaktree Acquisition Corp. III Life Sciences City Office REIT Forge Global Brooge Energy Silvercrest Asset Management Group Keen Vision Acquisition Ellington Credit Melar Acquisition Corp. I Alpine Income Property Trust Helix Acquisition Corp. II Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Nukkleus (NASDAQ:NUKK) are both small-cap trading companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Which has better earnings and valuation, OACC or NUKK? Oaktree Acquisition Corp. III Life Sciences has higher earnings, but lower revenue than Nukkleus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/ANukkleus$5.91M7.49-$8.52MN/AN/A Does the media favor OACC or NUKK? In the previous week, Nukkleus had 1 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 2 mentions for Nukkleus and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Nukkleus' score of 1.28 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media. Company Overall Sentiment Oaktree Acquisition Corp. III Life Sciences Very Positive Nukkleus Positive Is OACC or NUKK more profitable? Oaktree Acquisition Corp. III Life Sciences' return on equity of 0.00% beat Nukkleus' return on equity.Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A Nukkleus N/A -190.32%2,304.10% Do insiders & institutionals believe in OACC or NUKK? 12.5% of Nukkleus shares are owned by institutional investors. 14.9% of Nukkleus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryNukkleus beats Oaktree Acquisition Corp. III Life Sciences on 5 of the 7 factors compared between the two stocks. Get Nukkleus News Delivered to You Automatically Sign up to receive the latest news and ratings for NUKK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUKK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUKK vs. The Competition Export to ExcelMetricNukkleusTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$44.65M$2.43B$15.06B$9.31BDividend YieldN/A1.46%2.76%4.09%P/E RatioN/A31.0228.1819.69Price / Sales7.4939.1244.27100.25Price / CashN/A43.7226.2457.53Price / Book-2.346.086.445.67Net Income-$8.52M$33.22M$196.70M$257.51M7 Day Performance-10.02%-0.27%-0.05%-0.16%1 Month Performance-25.75%9.70%6.47%9.89%1 Year Performance193.90%24.51%18.56%15.08% Nukkleus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUKKNukkleusN/A$7.90-0.9%N/A+182.6%$44.65M$5.91M0.0012Positive NewsOACCOaktree Acquisition Corp. III Life SciencesN/A$10.41-0.3%N/AN/A$234.13MN/A0.00N/ACIOCity Office REIT3.0448 of 5 stars$5.50-1.8%N/A-0.5%$226.01M$171.13M-8.4620FRGEForge Global2.7694 of 5 stars$18.06-1.2%$38.25+111.8%-29.4%$225.36M$79.33M-3.483BROGBrooge EnergyN/A$2.54+10.2%N/A+188.1%$223.18M$81.54M0.0070News CoverageGap UpHigh Trading VolumeSAMGSilvercrest Asset Management Group3.3301 of 5 stars$16.32-1.2%N/A-6.6%$221.53M$123.65M17.18150Positive NewsKVACKeen Vision AcquisitionN/A$11.42+0.3%N/A+7.3%$220.58MN/A0.00N/AUpcoming EarningsEARNEllington Credit1.306 of 5 stars$5.77+0.2%$6.00+4.0%-17.0%$216.34M$15.88M-44.38170Positive NewsAnalyst ForecastMACIMelar Acquisition Corp. IN/A$10.52+0.1%N/AN/A$213.24MN/A0.00N/APINEAlpine Income Property Trust3.7848 of 5 stars$14.51-0.9%$18.97+30.8%-13.6%$208.87M$52.23M181.40N/AUpcoming EarningsAnalyst ForecastHLXBHelix Acquisition Corp. IIN/A$10.65+0.0%N/A+4.2%$201.19MN/A0.00N/A Related Companies and Tools Related Companies Oaktree Acquisition Corp. III Life Sciences Competitors City Office REIT Competitors Forge Global Competitors Brooge Energy Competitors Silvercrest Asset Management Group Competitors Keen Vision Acquisition Competitors Ellington Credit Competitors Melar Acquisition Corp. I Competitors Alpine Income Property Trust Competitors Helix Acquisition Corp. II Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUKK) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nukkleus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nukkleus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
